Pathobiology of junctional adhesion molecules

Antioxidants and Redox Signaling

Volumn 15, Issue 5, 2011, Pages 1221-1234

  Bazzoni, Gianfranco ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE C; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; EXTRAVASATION; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIA; LEUKOCYTE; MOLECULAR INTERACTION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REPERFUSION INJURY; REVIEW; TUMOR CELL;

ANIMALS; CELL ADHESION MOLECULES; HUMANS; INFLAMMATION; LEUKOCYTES; NEOPLASMS; PROTEIN BINDING; TIGHT JUNCTIONS; VASCULAR DISEASES;

EID: 79960756426     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3867     Document Type: Review

References (139)

1. Arrate MP, Rodriguez JM, Tran TM, Brock TA, and Cunningham SA. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem 276: 45826-45832, 2001.
2. Atmanene C, Wagner-Rousset E, Malissard M, Chol B, Robert A, and Corvaia N, et al. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. Anal Chem 81: 6364-6373, 2009.
3. Aurrand-Lions M, Duncan L, Ballestrem C, and Imhof BA. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem 276: 2733-2741, 2001.
4. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, and Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98: 3699-3707, 2001.
5. Aurrand-Lions M, Lamagna C, Dangerfield JP, Wang S, Herrera P, and Nourshargh S, et al. Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation. J Immunol 174: 6406-6415, 2005. (Pubitemid 40663834)
6. Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, and Sobocka MB, et al. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost 97: 272-281, 2007. (Pubitemid 46592148)
7. Babinska A, Kedees MH, Athar H, Ahmed T, Batuman O, and Ehrlich YH, et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost 88: 843-850, 2002. (Pubitemid 35350778)
8. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, and Schnell FJ, et al. Junction adhesion molecule is a receptor for reovirus. Cell 104: 441-451, 2001. (Pubitemid 32206464)
9. Bazzoni G. Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost 95: 36-42, 2006.
10. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 15: 525-530, 2003. (Pubitemid 37176960)
11. Bazzoni G and Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84: 869-901, 2004. (Pubitemid 38823769)
12. Bazzoni G, Martinez-Estrada OM, Mueller F, Nelboeck P, Schmid G, and Bartfai T, et al. Homophilic interaction of junctional adhesion molecule. J Biol Chem 275: 30970-30976, 2000.
13. Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, and Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275: 20520-20526, 2000. (Pubitemid 30457633)
14. Bazzoni G, Tonetti P, Manzi L, Cera MR, Balconi G, and Dejana E. Expression of junctional adhesion molecule-A prevents spontaneous and random motility. J Cell Sci 118: 623-632, 2005. (Pubitemid 40310128)
15. Blasig IE, Bellmann C, Cording J, del Vecchio G, Zwanziger D, Huber O, and Haseloff RF. Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal 15: 1195-1219, 2011.
16. Boettner B, Govek EE, Cross J, and Van Aelst L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc Natl Acad Sci USA 97: 9064-9069, 2000. (Pubitemid 30626674)
17. Bradfield PF, Nourshargh S, Aurrand-Lions M, and Imhof BA. JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 27: 2104-2112, 2007. (Pubitemid 350287237)
18. Bradfield PF, Scheiermann C, Nourshargh S, Ody C, Luscinskas FW, and Rainger GE. JAM-C regulates unidirectional monocyte transendothelial migration in inflammation. Blood 110: 2545-2555, 2007. (Pubitemid 47523177)
19. Carrano A, Hoozemans JJM, van der Vies SM, Rozemuller AJM, van Horssen J, and de Vries HE. Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 15: 1167-1178, 2011.
20. Cavusoglu E, Kornecki E, Sobocka MB, Babinska A, Ehrlich YH, and Chopra V. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J Am Coll Cardiol 50: 1768-1776, 2007. (Pubitemid 47600581)
21. Cera MR, Del Prete A, Vecchi A, Corada M, Martin-Padura I, and Motoike T, et al. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 114: 729-738, 2004. (Pubitemid 39578763)
22. Cera MR, Fabbri M, Molendini C, Corada M, Orsenigo F, and Rehberg M, et al. JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci 122: 268-277, 2009.
23. Chavakis T, Keiper T, Matz-Westphal R, Hersemeyer K, Sachs UJ, and Nawroth PP, et al. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem 279: 55602-55608, 2004. (Pubitemid 40066564)
24. Chavakis T, Preissner KT, and Santoso S. Leukocyte transendothelial migration: JAMs add new pieces to the puzzle. Thromb Haemost 89: 13-17, 2003. (Pubitemid 36149787)
25. Chretien I, Marcuz A, Courtet M, Katevuo K, Vainio O, and Heath JK, et al. CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates. Eur J Immunol 28: 4094-4104, 1998. (Pubitemid 28558639)
26. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, and Bergelson JM. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98: 15191-15196, 2001. (Pubitemid 34013991)
27. Coisne C and Engelhardt B. Tight junctions in brain barriers during CNS inflammation. Antioxid Redox Signal 15: 1285-1303, 2011.
28. Conn EM, Madsen MA, Cravatt BF, Ruf W, Deryugina EI, and Quigley JP. Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J Biol Chem 283: 26518-26527, 2008.
29. Cooke VG, Naik MU, and Naik UP. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler Thromb Vasc Biol 26: 2005-2011, 2006. (Pubitemid 44253781)
30. Corada M, Chimenti S, Cera MR, Vinci M, Salio M, and Fiordaliso F, et al. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc Natl Acad Sci USA 102: 10634-10639, 2005. (Pubitemid 41061606)
31. Coyne CB, Voelker T, Pichla SL, and Bergelson JM. The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction. J Biol Chem 279: 48079-48084, 2004. (Pubitemid 39540961)
32. Cunningham SA, Arrate MP, Rodriguez JM, Bjercke RJ, Vanderslice P, and Morris AP, et al. A novel protein with homology to the junctional adhesion molecule: characterization of leukocyte interactions. J Biol Chem 275: 34750-34756, 2000.
33. Cunningham SA, Rodriguez JM, Arrate MP, Tran TM, and Brock TA. JAM2 interacts with alpha4beta1: facilitation by JAM3. J Biol Chem 277: 27589-27592, 2002.
34. Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, and Fruscella P, et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 190: 1351-1356, 1999. (Pubitemid 29522218)
35. Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, and Zander K, et al. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J Cell Sci 116: 3879-3891, 2003. (Pubitemid 37279304)
36. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG, and Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 275: 27979-27988, 2000.
37. Ebnet K, Suzuki A, Horikoshi Y, Hirose T, Meyer Zu Brickwedde MK, and Ohno S, et al. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 20: 3738-3748, 2001. (Pubitemid 32691785)
38. Ebnet K, Suzuki A, Ohno S, and Vestweber D. Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117: 19-29, 2004. (Pubitemid 38072117)
39. Fraemohs L, Koenen RR, Ostermann G, Heinemann B, and Weber C. The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J Immunol 173: 6259-6264, 2004. (Pubitemid 39487784)
40. Frey T and Antonetti DA. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal 15: 1271-1284, 2011.
41. Fukuhara A, Irie K, Nakanishi H, Takekuni K, Kawakatsu T, and Ikeda W, et al. Involvement of nectin in the localization of junctional adhesion molecule at tight junctions. Oncogene 21: 7642-7655, 2002. (Pubitemid 35398811)
42. Fuse C, Ishida Y, Hikita T, Asai T, and Oku N. Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J Biol Chem 282: 8276-8283, 2007. (Pubitemid 47093624)
43. González-Mariscal L, Quirós M, and Díaz- Coránguez M. ZO proteins and redox-dependent processes. Antioxid Redox Signal 15: 1235-1253, 2011.
44. Hamazaki Y, Itoh M, Sasaki H, Furuse M, and Tsukita S. Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277: 455-461, 2002. (Pubitemid 34952079)
45. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
46. Hirabayashi S, Tajima M, Yao I, Nishimura W, Mori H, and Hata Y. JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol Cell Biol 23: 4267-4282, 2003. (Pubitemid 36666429)
47. Hirata K, Ishida T, Penta K, Rezaee M, Yang E, and Wohlgemuth J, et al. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 276: 16223-16231, 2001.
48. Huang H, Cruz F, and Bazzoni G. Junctional adhesion molecule-A regulates cell migration and resistance to shear stress. J Cell Physiol 209: 122-130, 2006. (Pubitemid 44318673)
49. Imhof BA, Zimmerli C, Gliki G, Ducrest-Gay D, Juillard P, and Hammel P, et al. Pulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-Cdeficient mice. J Pathol 212: 198-208, 2007. (Pubitemid 46852098)
50. Ishida T, Kundu RK, Yang E, Hirata K, Ho YD, and Quertermous T. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J Biol Chem 278: 34598-34608, 2003.
51. Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T, and Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 154: 491-497, 2001. (Pubitemid 34286156)
52. John LJ, Fromm M, and Schulzke JD. Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 15: 1255-1270, 2011.
53. Johnson-Leger CA, Aurrand-Lions M, Beltraminelli N, Fasel N, and Imhof BA. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood 100: 2479-2486, 2002.
54. Kansaku A, Hirabayashi S, Mori H, Fujiwara N, Kawata A, and Ikeda M, et al. Ligand-of-Numb protein X is an endocytic scaffold for junctional adhesion molecule 4. Oncogene 25: 5071-5084, 2006. (Pubitemid 44285977)
55. Keiper T, Al-Fakhri N, Chavakis E, Athanasopoulos AN, Isermann B, and Herzog S, et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J 19: 2078-2080, 2005. (Pubitemid 41759771)
56. Khandoga A, Kessler JS, Meissner H, Hanschen M, Corada M, and Motoike T, et al. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 106: 725-733, 2005. (Pubitemid 40981273)
57. Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, and Schwarz N, et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 113: 4799-4809, 2009.
58. Kornecki E, Walkowiak B, Naik UP, and Ehrlich YH. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 265: 10042-10048, 1990.
59. Kostrewa D, Brockhaus M, D'Arcy A, Dale GE, Nelboeck P, and Schmid G, et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 20: 4391-4398, 2001. (Pubitemid 32772033)
60. Lamagna C, Hodivala-Dilke KM, Imhof BA, and Aurrand-Lions M. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res 65: 5703-5710, 2005. (Pubitemid 40911173)
61. Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, and Jones EY, et al. Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell 16: 4992-5003, 2005. (Pubitemid 41416476)
62. Langer HF, Daub K, Braun G, Schonberger T, May AE, and Schaller M, et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 27: 1463-1470, 2007. (Pubitemid 46809439)
63. Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, and Babbin BA, et al. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 204: 3067-3976, 2007.
64. Lechner F, Sahrbacher U, Suter T, Frei K, Brockhaus M, and Koedel U, et al. Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection. J Infect Dis 182: 978-982, 2000.
65. Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, and Bauer H. Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal 15: 1305-1323, 2011.
66. Li X, Stankovic M, Lee BP, Aurrand-Lions M, Hahn CN, and Lu Y, et al. JAM-C induces endothelial cell permeability through its association and regulation of {beta}3 integrins. Arterioscler Thromb Vasc Biol 29: 1200-1206, 2009.
67. Liang TW, Chiu HH, Gurney A, Sidle A, Tumas DB, and Schow P, et al. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J Immunol 168: 1618-1626, 2002. (Pubitemid 34135756)
68. Liang TW, DeMarco RA, Mrsny RJ, Gurney A, Gray A, and Hooley J, et al. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol 279: C1733-C1743, 2000.
69. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, and Pochet M, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113: 2363-2374, 2000. (Pubitemid 30599341)
70. Ludwig RJ, Hardt K, Hatting M, Bistrian R, Diehl S, and Radeke HH, et al. Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin. Immunology 128: 196-205, 2009.
71. Ludwig RJ, Zollner TM, Santoso S, Hardt K, Gille J, and Baatz H, et al. Junctional adhesion molecules (JAM)-B and-C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol 125: 969-976, 2005.
72. Luissint AC, Lutz PG, Calderwood DA, Couraud PO, and Bourdoulous S. JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation. J Cell Biol 183: 1159-1173, 2008.
73. Mamdouh Z, Mikhailov A, and Muller WA. Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J Exp Med 206: 2795-2808, 2009.
74. Mandell KJ, Babbin BA, Nusrat A, and Parkos CA. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem 280: 11665-11674, 2005. (Pubitemid 40418481)
75. Mandell KJ, McCall IC, and Parkos CA. Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem 279: 16254-16262, 2004. (Pubitemid 38509319)
76. Mandell KJ and Parkos CA. The JAM family of proteins. Adv Drug Deliv Rev 57: 857-867, 2005. (Pubitemid 40488107)
77. Mandicourt G, Iden S, Ebnet K, Aurrand-Lions M, and Imhof BA. JAM-C regulates tight junctions and integrinmediated cell adhesion and migration. J Biol Chem 282: 1830-1837, 2007. (Pubitemid 47076730)
78. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, and Fruscella P, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142: 117-127, 1998. (Pubitemid 28341144)
79. Martinez-Estrada OM, Manzi L, Tonetti P, Dejana E, and Bazzoni G. Opposite effects of tumor necrosis factor and soluble fibronectin on junctional adhesion molecule-A in endothelial cells. Am J Physiol Lung Cell Mol Physiol 288: L1081-L1088, 2005. (Pubitemid 40695433)
80. Martinez-Estrada OM, Villa A, Breviario F, Orsenigo F, Dejana E, and Bazzoni G. Association of junctional adhesion molecule with calcium/calmodulin- dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J Biol Chem 276: 9291-9296, 2001.
81. McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, and Landberg G, et al. JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 125: 1343-1351, 2009.
82. Mirza M, Hreinsson J, Strand ML, Hovatta O, Soder O, and Philipson L, et al. Coxsackievirus and adenovirus receptor (CAR) is expressed in male germ cells and forms a complex with the differentiation factor JAM-C in mouse testis. Exp Cell Res 312: 817-830, 2006.
83. Mirza M, Raschperger E, Philipson L, Pettersson RF, and Sollerbrant K. The cell surface protein coxsackie-and adenovirus receptor (CAR) directly associates with the Ligandof-Numb Protein-X2 (LNX2). Exp Cell Res 309: 110-120, 2005. (Pubitemid 41191228)
84. Moog-Lutz C, Cave-Riant F, Guibal FC, Breau MA, Di Gioia Y, and Couraud PO, et al. JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells. Blood 102: 3371-3378, 2003. (Pubitemid 37314780)
85. Murakami M, Francavilla C, Torselli I, Corada M, Maddaluno L, and Sica A, et al. Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration. Cancer Res 70: 1759-1765, 2010.
86. Naik MU, Mousa SA, Parkos CA, and Naik UP. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood 102: 2108-2114, 2003. (Pubitemid 37122387)
87. Naik MU, Naik TU, Suckow AT, Duncan MK, and Naik UP. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68: 2194-2203, 2008. (Pubitemid 351521792)
88. Naik MU and Naik UP. Junctional adhesion molecule-Ainduced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. J Cell Sci 119: 490-499, 2006.
89. Naik MU, Vuppalanchi D, and Naik UP. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 23: 2165-2171, 2003. (Pubitemid 37532315)
90. Naik TU, Naik MU, and Naik UP. Junctional adhesion molecules in angiogenesis. Front Biosci 13: 258-262, 2008. (Pubitemid 351594776)
91. Naik UP, Naik MU, Eckfeld K, Martin-DeLeon P, and Spychala J. Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody. J Cell Sci 114: 539-547, 2001. (Pubitemid 32186111)
92. Nasdala I, Wolburg-Buchholz K, Wolburg H, Kuhn A, Ebnet K, and Brachtendorf G, et al. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J Biol Chem 277: 16294-16303, 2002. (Pubitemid 34967918)
93. Nourshargh S, Krombach F, and Dejana E. The role of JAMA and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol 80: 714-718, 2006. (Pubitemid 44835886)
94. Ong KL, Leung RY, Wong LY, Cherny SS, Sham PC, and Lam TH, et al. Association of F11 receptor gene polymorphisms with central obesity and blood pressure. J Intern Med 263: 322-332, 2008. (Pubitemid 351207343)
95. Orlova VV, Economopoulou M, Lupu F, Santoso S, and Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 203: 2703-2714, 2006. (Pubitemid 44833346)
96. Ostermann G, Fraemohs L, Baltus T, Schober A, Lietz M, and Zernecke A, et al. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol 25: 729-735, 2005. (Pubitemid 40463861)
97. Ostermann G, Weber KS, Zernecke A, Schroder A, and Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3: 151-158, 2002. (Pubitemid 34141445)
98. Overgaard CE, Daugherty BL, Mitchell LA, and Koval M. Claudins: control of barrier function and regulation in response to oxidant stress. Antioxid Redox Signal 15: 1179-1193, 2011.
99. Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, and Okawa K, et al. Cutting edge: combined treatment of TNFalpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 163: 553-557, 1999. (Pubitemid 29328054)
100. Padden M, Leech S, Craig B, Kirk J, Brankin B, and McQuaid S. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol 113: 177-186, 2007. (Pubitemid 46158150)
101. Palmer G, Busso N, Aurrand-Lions M, Talabot-Ayer D, Chobaz-Peclat V, and Zimmerli C, et al. Expression and function of junctional adhesion molecule-C in human and experimental arthritis. Arthritis Res Ther 9: R65, 2007.
102. Palmeri D, van Zante A, Huang CC, Hemmerich S, and Rosen SD. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem 275: 19139-19145, 2000. (Pubitemid 30422883)
103. Paris L, Tonutti L, Vannini C, and Bazzoni G. Structural organization of the tight junctions. Biochim Biophys Acta 1778: 646-659, 2008. (Pubitemid 351317797)
104. Parise LV. JAM-1 regulation of endothelial cell migration: implications for angiogenesis. Arterioscler Thromb Vasc Biol 23: 2119-2120, 2003. (Pubitemid 37532308)
105. Prasad A, Stone GW, Holmes DR, and Gersh B. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion. Circulation 120: 2105-2112, 2009.
106. Prota AE, Campbell JA, Schelling P, Forrest JC, Watson MJ, and Peters TR, et al. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci USA 100: 5366-5371, 2003. (Pubitemid 36542711)
107. Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK 3rd, and Imhof BA, et al. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum 58: 3020-3029, 2008.
108. Santoso S, Orlova VV, Song K, Sachs UJ, Andrei-Selmer CL, and Chavakis T. The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem 280: 36326-36333, 2005. (Pubitemid 41633906)
109. Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, and Preissner KT, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 196: 679-691, 2002. (Pubitemid 35024445)
110. Scheiermann C, Colom B, Meda P, Patel NS, Voisin MB, and Marrelli A, et al. Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury. Arterioscler Thromb Vasc Biol 29: 1509-1515, 2009.
111. Severson EA, Jiang L, Ivanov AI, Mandell KJ, Nusrat A, and Parkos CA. Cis-dimerization mediates function of junctional adhesion molecule A. Mol Biol Cell 19: 1862-1872, 2008.
112. Severson EA, Lee WY, Capaldo CT, Nusrat A, and Parkos CA. Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. Mol Biol Cell 20: 1916-1925, 2009.
113. Severson EA and Parkos CA. Mechanisms of outside-in signaling at the tight junction by junctional adhesion molecule A. Ann N Y Acad Sci 1165: 10-18, 2009.
114. Severson EA and Parkos CA. Structural determinants of junctional adhesion molecule A (JAM-A) function and mechanisms of intracellular signaling. Curr Opin Cell Biol 21: 701-707, 2009.
115. Shagdarsuren E, Djalali-Talab Y, Aurrand-Lions M, Bidzhekov K, Liehn EA, and Imhof BA, et al. Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone micebrief report. Arterioscler Thromb Vasc Biol 29: 1161-1163, 2009.
116. Shaw SK, Ma S, Kim MB, Rao RM, Hartman CU, and Froio RM, et al. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med 200: 1571-1580, 2004. (Pubitemid 40094181)
117. Shaw SK, Perkins BN, Lim YC, Liu Y, Nusrat A, and Schnell FJ, et al. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow. Am J Pathol 159: 2281-2291, 2001. (Pubitemid 33104281)
118. Sircar M, Bradfield PF, Aurrand-Lions M, Fish RJ, Alcaide P, and Yang L, et al. Neutrophil transmigration under shear flow conditions in vitro is junctional adhesion molecule-C independent. J Immunol 178: 5879-5887, 2007. (Pubitemid 46674385)
119. Slevin M, Elasbali AB, Miguel Turu M, Krupinski J, Badimon L, and Gaffney J. Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol 168: 1004-1021, 2006. (Pubitemid 43327751)
120. Sobocka MB, Sobocki T, Banerjee P, Weiss C, Rushbrook JI, and Norin AJ, et al. Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood 95: 2600-2609, 2000. (Pubitemid 30210539)
121. Sollerbrant K, Raschperger E, Mirza M, Engstrom U, Philipson L, Ljungdahl PO, et al. The coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX). J Biol Chem 278: 7439-7444, 2003. (Pubitemid 36800749)
122. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994. (Pubitemid 24046692)
123. Stellos K, Langer H, Gnerlich S, Panagiota V, Paul A, and Schonberger T, et al. Junctional adhesion molecule A expressed on human CD34 + cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells. Arterioscler Thromb Vasc Biol 30: 1127-1136.
124. Tenan M, Aurrand-Lions M, Widmer V, Alimenti A, Burkhardt K, and Lazeyras F, et al. Cooperative expression of junctional adhesion molecule-C and-B supports growth and invasion of glioma. Glia 58: 524-537, 2010.
125. Vetrano S and Danese S. The role of JAM-A in inflammatory bowel disease: unrevealing the ties that bind. Ann N Y Acad Sci 1165: 308-313, 2009.
126. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, and Doni A, et al. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 135: 173-184, 2008. (Pubitemid 351899025)
127. Vonlaufen A, Aurrand-Lions M, Pastor CM, Lamagna C, Hadengue A, and Imhof BA, et al. The role of junctional adhesion molecule C (JAM-C) in acute pancreatitis. J Pathol 209: 540-548, 2006. (Pubitemid 44194569)
128. Waki H, Gouraud SS, Maeda M, and Paton JF. Specific inflammatory condition in nucleus tractus solitarii of the SHR: novel insight for neurogenic hypertension? Auton Neurosci 142: 25-31, 2008.
129. Waki H, Liu B, Miyake M, Katahira K, Murphy D, and Kasparov S, et al. Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension 49: 1321-2327, 2007.
130. Weber C, Fraemohs L, and Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7: 467-477, 2007. (Pubitemid 46834851)
131. Wegmann F, Ebnet K, Du Pasquier L, Vestweber D, and Butz S. Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts. Exp Cell Res 300: 121-133, 2004. (Pubitemid 39286222)
132. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, and Volkery S, et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 203: 1671-1677, 2006. (Pubitemid 44036272)
133. Williams LA, Martin-Padura I, Dejana E, Hogg N, and Simmons DL. Identification and characterisation of human junctional adhesion molecule (JAM). Mol Immunol 36: 1175-1188, 1999. (Pubitemid 30078900)
134. Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, and Weber C, et al. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J 96: 285-293, 2009.
135. Woodfin A, Reichel CA, Khandoga A, Corada M, Voisin MB, and Scheiermann C, et al. JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 110: 1848-1856, 2007. (Pubitemid 47443896)
136. Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, and Nourshargh S. Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood 113: 6246-6257, 2009.
137. Zen K, Babbin BA, Liu Y, Whelan JB, Nusrat A, and Parkos CA. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell 15: 3926-3937, 2004. (Pubitemid 38989725)
138. Zen K, Liu Y, McCall IC, Wu T, Lee W, and Babbin BA, et al. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion moleculelike protein on neutrophils. Mol Biol Cell 16: 2694-2703, 2005. (Pubitemid 40741217)
139. Zernecke A, Liehn EA, Fraemohs L, von Hundelshausen P, Koenen RR, and Corada M, et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 26: e10-e13, 2006. (Pubitemid 43732185)